Dinur, T.; Grittner, U.; Revel-Vilk, S.; Becker-Cohen, M.; Istaiti, M.; Cozma, C.; Rolfs, A.; Zimran, A.
Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations. Int. J. Mol. Sci. 2021, 22, 7699.
https://doi.org/10.3390/ijms22147699
AMA Style
Dinur T, Grittner U, Revel-Vilk S, Becker-Cohen M, Istaiti M, Cozma C, Rolfs A, Zimran A.
Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations. International Journal of Molecular Sciences. 2021; 22(14):7699.
https://doi.org/10.3390/ijms22147699
Chicago/Turabian Style
Dinur, Tama, Ulrike Grittner, Shoshana Revel-Vilk, Michal Becker-Cohen, Majdolen Istaiti, Claudia Cozma, Arndt Rolfs, and Ari Zimran.
2021. "Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations" International Journal of Molecular Sciences 22, no. 14: 7699.
https://doi.org/10.3390/ijms22147699
APA Style
Dinur, T., Grittner, U., Revel-Vilk, S., Becker-Cohen, M., Istaiti, M., Cozma, C., Rolfs, A., & Zimran, A.
(2021). Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations. International Journal of Molecular Sciences, 22(14), 7699.
https://doi.org/10.3390/ijms22147699
